Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Crohn's Disease: Risankizumab as Induction- and Maintenance Therapy Comment (2022) Atreya R Journal article, Editorial Constrained multiple instance learning for ulcerative colitis prediction using histological images (2022) Del Amor R, Meseguer P, Parigi TL, Villanacci V, Colomer A, Launet L, Bazarova A, et al. Journal article High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent (2022) Merola E, Perren A, Rinke A, Zerbi A, Mcnamara MG, Arsenic R, Fazio N, et al. Journal article Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time? (2022) Hope TA, Pavel ME, Bergsland EK Journal article, Review article DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms (2022) Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, et al. Journal article, Review article Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment (2022) Bouhnik Y, Atreya R, Casey D, Gorecki M, Baik D, Yoon SW, Kwon TS, Jang M Journal article Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis-A case report and literature review (2022) Yalcin Mutlu M, Taubmann J, Wacker J, Tascilar K, Fagni F, Gerner M, Klett D, et al. Journal article Store-operated calcium entry is reduced in spastin-linked hereditary spastic paraplegia (2022) Winner B, Rizo Garza T, Gebhardt L, Riedlberger J, Eberhardt E, Fester L, Alansary D, et al. Other publication type Immuntherapie bei neuroendokrinen Tumoren: Zeitpunkt und Zielgruppe (2022) Auernhammer CJ, Pavel ME Journal article Rear Window—What Can the Gut Tell Us About Long-COVID? (2022) Leppkes M, Neurath M Journal article